RMD ResMed Inc.

236.88USD-2.36%Mkt Cap: 33.32B USDP/E: 21.57

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap33.32B USD
Enterprise Value33.72B USD
Revenue (TTM)5.73B USD
Gross Profit3.45B USD
Net Income (TTM)1.52B USD
Revenue/Share39.61 USD
Last Price236.88 USD
Fiscal Year EndJun 2026
MR QuarterSep 2026
Employees11.4K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)21.57
P/E (Forward)17.91
PEG1.30
EV/EBITDA15.86
EV/Revenue5.88
P/S5.81
P/B5.60
EPS (TTM)10.98 USD
EPS (Forward)13.23 USD
52W Range
180.2658% of range277.67
52W High277.67 USD
52W Low180.26 USD
Profitability
Gross Margin61.06%
Oper. Margin34.02%
EBITDA Margin37.09%
Profit Margin26.94%
ROE23.13%
ROA16.99%
ROIC25.49%
ROCE25.21%
Growth
Revenue Growth5.90%
Earnings Growth23.20%
Cash Flow & Leverage
Operating CF1.81B USD
CapEx (TTM)177.17M USD
FCF Margin22.64%
FCF Yield3.90%
Net Debt-400.16M USD
Net Debt/EBITDA-0.19
Net Debt/FCF-0.31
Balance Sheet
Debt/Equity0.13
Current Ratio2.65
Quick Ratio1.54
Book Value/Sh42.29 USD
Cash/Share7.19 USD
Dividends
Fwd Div Rate2.64 USD
Trail. Div Rate2.46 USD
Div. Yield1.09%
5Y Avg Yield0.87%
Payout Ratio22.40%
Ex-Div DateNov 12, 2026
Pay DateDec 17, 2026
Splits
Last Split2:1
Split DateAug 31, 2010
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)264.33 USD
Upside (mean)+11.6%
Target Range210.00 USD – 320.00 USD
210.00+11.6% to mean320.00
# Analysts17
Ownership
Shares Out.140.66M
Float139.80M
Insiders0.51%
Institutions68.54%
Short Interest
Short Ratio8.5d
Short % Float7.48%
Short % Out.7.44%
Shares Short10.47M
Short (prev mo.)12.78M
Technical
SMA 50232.35 (+1.9%)
SMA 200223.77 (+5.9%)
Beta0.76
S&P 52W Chg12.08%
Avg Vol (30d)1.32M
Avg Vol (10d)1.42M
Technical Indicators
RSI (14)49.0
MACD0.7829
MACD Signal1.2437
MACD Hist.-0.4608
BB Upper255.88 USD
BB Middle240.36 USD
BB Lower224.85 USD
BB Width12.91%
ATR (14)7.278 USD
Vol Ratio (20d)0.79x

About ResMed (NYSE: RMD)

›

ResMed (NYSE: RMD) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 11,370 employees.

The shares were at 236.88 USD on 19 November 2026, down 2.6% over 52 weeks. Its 52-week range is 180.26 USD to 277.67 USD: the price is 14.7% below the high and 31.4% above the low.

At a market capitalisation of 33.32B USD, it trades at 21.6 times trailing earnings and 17.9 times forward earnings. The median trailing P/E of its 18 largest Medical Instruments & Supplies peers is 51.8, a discount of 58% for RMD. It pays a dividend yielding 1.09% (it pays out 22% of its earnings), against a median of 0.48% among the dividend payers in that peer group.

ResMed reports return on equity of 23.1%, an operating margin of 34.0% and revenue up 5.9% year over year.

It holds more cash than debt, a net cash position of 400.16M USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 17 analysts cover the stock, with an average rating of Buy; their mean price target of 264.33 USD is 11.6% above the current price. The next earnings report is expected on 28 January 2027.